Fluorinated 4-azasteroid derivatives as androgen receptor modulators
Details for Australian Patent Application No. 2003218235 (hide)
International Classifications
Event Publications
31 July 2003 Complete Application Filed
Priority application(s): 60/363,822 13.03.02 US
6 November 2003 Application Open to Public Inspection
Published as AU-B-2003218235
15 May 2008 Application Accepted
Published as AU-B-2003218235
11 September 2008 Standard Patent Sealed
21 January 2010 Amendment Made
The nature of the amendment is: Amend the patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.
4 October 2012 Alteration of Name
The name of the patentee has been altered to Merck Sharp & Dohme Corp.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003218234-METHODS OF EXPRESSING NONENDOGENOUS G PROTEIN COUPLED RECEPTORS IN CELLS
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser